XENE Competitors & Alternatives
Compare Xenon Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
XENE
Main Stock$35.95
Tradestie Score
60
Market Cap
$3.02B
Revenue Growth
-1.0%
Analyst Upside
+101.5%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$16.34
|
$3.68B | - | 49 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$83.44
|
$3.67B | - | 63 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$11.01
|
$3.59B | 16.0 | 27 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$20.19
|
$3.58B | 8.9 | 71 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$314.78
|
$3.49B | 32.3 | 52 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$10.03
|
$3.40B | 111.6 | 48 | Compare |
|
QURE
uniQure N.V.
|
$22.69
|
$3.39B | - | 63 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$43.00
|
$3.33B | - | 69 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$21.49
|
$3.31B | - | 51 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 48 | Compare |
More XENE Analysis
Data updated: Oct 21, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry